The Rosen Law Firm has announced class action securities lawsuits against three companies: Taboola.com Ltd (TBLA) for allegedly misrepresenting publisher quality and contract valuations, Celsius Holdings, Inc (CELH) for undisclosed losses, and XTI Aerospace, Inc (XTIA) for unspecified securities violations. Investors who purchased shares during specified periods are urged to seek legal counsel before upcoming filing deadlines.

The Rosen Law Firm has issued notices regarding class action securities lawsuits against three companies: Celsius Holdings (CELH) for allegedly failing to disclose health risks associated with its energy drink products and marketing to minors; Taboola.com (TBLA) with an October 20 deadline; and XTI Aerospace (XTIA) with an October 27 deadline. Investors who suffered losses exceeding $100,000 are urged to seek legal counsel.

Rosen Law Firm, a prominent investor rights firm, is notifying investors in Better Home & Finance Holding Company (BETR), Taboola.com Ltd (TBLA), and Celsius Holdings, Inc (CELH) of important class action lawsuit deadlines. The firm is seeking class members who purchased securities during specified periods and claims the companies made false or misleading statements regarding their business operations and financial prospects.

Robbins LLP is reminding investors about a class action lawsuit against Celsius Holdings (CELH) for allegedly misleading investors about the safety of Alani Nu energy drinks marketed to teenagers. The lawsuit covers the period from February 21, 2025 to June 3, 2026. The case was triggered by reports of a 17-year-old's death linked to the high-caffeine drinks and a subsequent investigation by the Texas Attorney General. The stock fell significantly following these revelations.

Robbins LLP reminds investors of a class action lawsuit against Beta Bionics (BBNX) for allegedly misleading investors about the safety and efficacy of its iLet insulin pump. The company failed to disclose serious FDA concerns about device malfunctions causing dangerously high insulin doses and hypoglycemic events. Stock fell from $31.99 to $12.89 per share between January and February 2026 following FDA warning letter disclosures.

The Portnoy Law Firm has filed a class action lawsuit on behalf of Celsius Holdings investors who purchased securities between February 21, 2025 and June 3, 2026. The lawsuit alleges that Celsius failed to disclose that its acquired Alani Nutrition drinks contain excessive caffeine (200mg per 12oz serving) and pose cardiac risks, particularly to minors under 18 whom the company allegedly targeted despite safety concerns. Investors have until November 3, 2026 to file a lead plaintiff motion.

Celsius Holdings (CELH) is trending but faces headwinds. The stock has underperformed the S&P 500 over the past month (+1.1% vs +2.1%). While revenue growth is solid at +26.6% for the current fiscal year, earnings estimates have declined over the past month, and the company received a Zacks Rank #4 (Sell) rating. The stock trades at a premium valuation (Grade D) and is expected to underperform the broader market in the near term.

A class action lawsuit has been filed against Celsius Holdings, Inc. alleging that the company made materially false and misleading statements regarding health risks associated with Alani Nu products, including inadequate disclosure of cardiac risks and marketing to minors. The lawsuit covers investors who purchased Celsius securities between February 21, 2025 and June 3, 2026. The lead plaintiff deadline is November 3, 2026.

Rosen Law Firm has filed class action lawsuits on behalf of investors in Celsius Holdings, Inc. and other companies. The Celsius lawsuit alleges that the company made materially false and misleading statements regarding cardiac risks associated with Alani Nu products and inappropriately marketed these products to consumers under 18. Investors who purchased securities during the specified class periods may be eligible for compensation. The deadline to serve as lead plaintiff is November 3, 2026.

Celsius Holdings (CELH) closed at $26.92, down 1.36%, underperforming the broader market. The stock has declined 7.68% over the past month. While full-year earnings are expected to grow 6.72% and revenue 26.6%, the upcoming quarter is projected to see a 19.05% year-over-year earnings decline. The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 19.03, trading at a premium to its industry average.

A class action lawsuit has been filed against Celsius Holdings (CELH) for allegedly making false and misleading statements about the safety of Alani Nu energy drinks, which contain 200mg of caffeine per 12oz serving. The complaint alleges the company marketed high-caffeine products to consumers under 18 despite known cardiac risks, following a wrongful death lawsuit involving a 17-year-old and a Texas Attorney General investigation. The stock fell significantly on news of the investigation.

A class action lawsuit has been filed against Celsius Holdings, Inc. alleging that the company made materially false and misleading statements regarding health risks associated with its Alani Nu products, including inadequate disclosure of cardiac risks and improper marketing to minors. Investors who purchased Celsius securities between February 21, 2025 and June 3, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 3, 2026.